Health science reports · 2026
Early Detection of Clinical Deterioration in ICU Patients With Respiratory Failure Receiving Vasoactive Support: A Machine Learning Approach to Identifying High-Risk Individuals.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Fathi Mohammad, Markazi Moghadam Hamed, Fathi Mahdis, Hajiesmaeili Mohammadreza, Nooraei Navid, Alamdari Nasser Malekpour, Jame Sanaz Zargar Balaye, Khataee Farhad Hashemnezhad, Moghaddam Nader Markazi
Аннотация
BACKGROUND AND AIMS: Acute respiratory failure requiring intensive care is frequently accompanied by hemodynamic instability, necessitating vasoactive pharmacologic support, and elevated mortality. We aimed to develop and validate a machine learning model to stratify all-cause in-hospital mortality risk in ICU patients with respiratory failure receiving vasoactive therapy.
METHODS: We performed a secondary analysis of the MIMIC-IV database, including adult ICU patients (2017-2022) with respiratory failure who received vasoactive medications. A random forest survival model was constructed to estimate individualized survival probabilities. Patients were subsequently stratified into two cohorts based on median predicted survival. A multivariable logistic regression model was used to profile clinical and laboratory characteristics associated with low- and high-risk groups.
RESULTS: The final cohort comprised 1951 adult patients. Using the random forest survival model (concordance index = 0.769), patients were categorized into low-risk and high-risk groups, with significantly different survival outcomes (log-rank test p < 0.001). The logistic regression model (p < 0.001, Nagelkerke R 2 = 0.714, Brier score = 0.102) achieved high performance (AUC = 0.924) in identifying high-risk individuals. High-risk patients were characterized by biomarkers of multiorgan dysfunction, including renal insufficiency, hepatic impairment, coagulopathy, acid-base disturbances, and systemic inflammation. In contrast, higher levels of hemoglobin, albumin, and arterial oxygen tension were associated with lower risk, indicative of preserved physiological reserve.
CONCLUSIONS: A machine learning model incorporating early-phase ICU data effectively stratified mortality risk in patients with respiratory failure receiving vasoactive support. This approach provides a clinically interpretable framework to inform prognostication, optimize resource allocation, and support data-driven decision-making.
METHODS: We performed a secondary analysis of the MIMIC-IV database, including adult ICU patients (2017-2022) with respiratory failure who received vasoactive medications. A random forest survival model was constructed to estimate individualized survival probabilities. Patients were subsequently stratified into two cohorts based on median predicted survival. A multivariable logistic regression model was used to profile clinical and laboratory characteristics associated with low- and high-risk groups.
RESULTS: The final cohort comprised 1951 adult patients. Using the random forest survival model (concordance index = 0.769), patients were categorized into low-risk and high-risk groups, with significantly different survival outcomes (log-rank test p < 0.001). The logistic regression model (p < 0.001, Nagelkerke R 2 = 0.714, Brier score = 0.102) achieved high performance (AUC = 0.924) in identifying high-risk individuals. High-risk patients were characterized by biomarkers of multiorgan dysfunction, including renal insufficiency, hepatic impairment, coagulopathy, acid-base disturbances, and systemic inflammation. In contrast, higher levels of hemoglobin, albumin, and arterial oxygen tension were associated with lower risk, indicative of preserved physiological reserve.
CONCLUSIONS: A machine learning model incorporating early-phase ICU data effectively stratified mortality risk in patients with respiratory failure receiving vasoactive support. This approach provides a clinically interpretable framework to inform prognostication, optimize resource allocation, and support data-driven decision-making.